Total (200) | 24- < 28 weeks (15) | 28- < 32 weeks (52) | 32- < 35 weeks (133) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
DCC (5) | UCM (10) | P- value | DCC (20) | UCM (32) | P- value | DCC (75) | UCM (58) | P- value | ||
Neonatal jaundice | 146 (73%) | 2 (40%) | 5 (50%) | 0.714 | 15 (75%) | 25 (78%) | 0.795 | 53 (71%) | 46 (79%) | 0.257 |
Phototherapy | 133 (66.5%) | 2 (40%) | 5 (50%) | 0.714 | 13 (65%) | 24 (75%) | 0.439 | 45 (60%) | 44 (76%) | 0.054 |
Need for inotropes | 22 (11%) | 1 (20%) | 6 (60%) | 0.143 | 4 (20%) | 8 (25%) | 0.677 | 1 (1.3%) | 2 (3.4%) | 0.415 |
Need for transfusion | 38 (19%) | 3 (60%) | 7 (70%) | 0.699 | 4 (20%) | 11 (34%) | 0.266 | 5 (6.7%) | 8 (14%) | 0.170 |
Intraventricular hemorrhage (IVH) | 14 (7%) | 3 (60%) | 2 (20%) | 0.121 | 2 (10%) | 6 (19%) | 0.395 | 0 | 1 (1.7%) | 0.254 |
Severe IVH (grade III, IV) | 5 (2.5%) | 1 (20%) | 1 (10%) | 0.591 | 0 | 3 (9.4%) | 0.158 | 0 | 0 | NA |
Periventricular leukomalacia | 3 (1.5%) | 0 | 0 | NA | 0 | 1 (3.1%) | 0.425 | 1 (1.3%) | 1 (1.7%) | 0.854 |
Necrotizing enterocolitis (NEC) | 8 (4%) | 1 (20%) | 2 (20%) | 1.00 | 1 (5%) | 1 (3.1%) | 0.732 | 0 | 3 (5.2%) | 0.046 |
Late onset Neonatal Sepsis | 40 (20%) | 3 (60%) | 7 (70%) | 0.699 | 10 (50%) | 10 (31%) | 0.176 | 2 (2.7%) | 8 (14%) | 0.016* |
Retinopathy | 10 (5%) | 3 (60%) | 3 (30%) | 0.264 | 1 (5%) | 3 (9.4%) | 0.565 | 0 | 0 | NA |
Patent ductus arteriosus medically managed | 33 (16.5%) | 3 (60%) | 3 (30%) | 0.264 | 4 (20%) | 12 (38%) | 0.183 | 7 (9.3%) | 4 (6.9%) | 0.613 |
Patent ductus arteriosus need surgical management | 1 (0.5%) | 0 | 1 (10%) | 0.464 | 0 | 0 | NA | 0 | 0 | NA |
Neonatal death before discharge | 17 (8.5%) | 2 (40%) | 5 (50%) | 0.714 | 2 (10%) | 6 (18.8%) | 0.395 | 0 | 2 (3.4%) | 0.105 |